These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
388 related articles for article (PubMed ID: 23819812)
1. Circulating miRNA-20a and miRNA-203 for screening lymph node metastasis in early stage cervical cancer. Zhao S; Yao D; Chen J; Ding N Genet Test Mol Biomarkers; 2013 Aug; 17(8):631-6. PubMed ID: 23819812 [TBL] [Abstract][Full Text] [Related]
2. Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma. Chen J; Yao D; Li Y; Chen H; He C; Ding N; Lu Y; Ou T; Zhao S; Li L; Long F Int J Mol Med; 2013 Sep; 32(3):557-67. PubMed ID: 23799609 [TBL] [Abstract][Full Text] [Related]
3. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer. Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145 [TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of miR-20a and miR-203 in cervical cancer. Zhao S; Yao DS; Chen JY; Ding N Asian Pac J Cancer Prev; 2013; 14(4):2289-93. PubMed ID: 23725129 [TBL] [Abstract][Full Text] [Related]
5. Serum miR-126 level combined with multi- detector computed tomography in the preoperative prediction of lymph node metastasis of gastric cancer. Feng R; Lu S; Sah BK; Beeharry MK; Zhang H; Yan M; Liu B; Li C; Zhu Z Cancer Biomark; 2018; 22(4):773-780. PubMed ID: 29843221 [TBL] [Abstract][Full Text] [Related]
6. A panel of six-circulating miRNA signature in serum and its potential diagnostic value in colorectal cancer. Maminezhad H; Ghanadian S; Pakravan K; Razmara E; Rouhollah F; Mossahebi-Mohammadi M; Babashah S Life Sci; 2020 Oct; 258():118226. PubMed ID: 32771555 [TBL] [Abstract][Full Text] [Related]
7. Serum microRNA-218 is a potential biomarker for esophageal cancer. Jiang Z; Song Q; Yang S; Zeng R; Li X; Jiang C; Ding W; Zhang J; Zheng Y Cancer Biomark; 2015; 15(4):381-9. PubMed ID: 25812647 [TBL] [Abstract][Full Text] [Related]
8. The level of circulating miRNA-10b and miRNA-373 in detecting lymph node metastasis of breast cancer: potential biomarkers. Chen W; Cai F; Zhang B; Barekati Z; Zhong XY Tumour Biol; 2013 Feb; 34(1):455-62. PubMed ID: 23238818 [TBL] [Abstract][Full Text] [Related]
9. Plasma miR-127 and miR-218 Might Serve as Potential Biomarkers for Cervical Cancer. You W; Wang Y; Zheng J Reprod Sci; 2015 Aug; 22(8):1037-41. PubMed ID: 25701838 [TBL] [Abstract][Full Text] [Related]
10. Serum miR-3142 could be Used as a Potential Biomarker to Screen Cervical Cancer Patients from Healthy Controls. Luo Q; Wang H; Li J Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969093 [TBL] [Abstract][Full Text] [Related]
11. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer. Geng Q; Fan T; Zhang B; Wang W; Xu Y; Hu H Respir Res; 2014 Nov; 15(1):149. PubMed ID: 25421010 [TBL] [Abstract][Full Text] [Related]
12. Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma. He FC; Meng WW; Qu YH; Zhou MX; He J; Lv P; Ming L World J Gastroenterol; 2015 Apr; 21(15):4660-5. PubMed ID: 25914476 [TBL] [Abstract][Full Text] [Related]
13. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer. Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-492 overexpression involves in cell proliferation, migration, and radiotherapy response of cervical squamous cell carcinomas. Liu M; An J; Huang M; Wang L; Tu B; Song Y; Ma K; Wang Y; Wang S; Zhu H; Xu N; Wu L Mol Carcinog; 2018 Jan; 57(1):32-43. PubMed ID: 28802022 [TBL] [Abstract][Full Text] [Related]
15. Plasma circulating microRNA-944 and microRNA-3662 as potential histologic type-specific early lung cancer biomarkers. Powrózek T; Krawczyk P; Kowalski DM; Winiarczyk K; Olszyna-Serementa M; Milanowski J Transl Res; 2015 Oct; 166(4):315-23. PubMed ID: 26079400 [TBL] [Abstract][Full Text] [Related]
16. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma. Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475 [TBL] [Abstract][Full Text] [Related]
17. Identification of circulating microRNA signatures as potential noninvasive biomarkers for prediction and prognosis of lymph node metastasis in gastric cancer. Jiang X; Wang W; Yang Y; Du L; Yang X; Wang L; Zheng G; Duan W; Wang R; Zhang X; Wang L; Chen X; Wang C Oncotarget; 2017 Sep; 8(39):65132-65142. PubMed ID: 29029418 [TBL] [Abstract][Full Text] [Related]
18. Preoperative Prediction of Lymph Node Status by Circulating Mir-18b and Mir-20a During Chemoradiotherapy in Patients with Rectal Cancer. Azizian A; Kramer F; Jo P; Wolff HA; Beißbarth T; Skarupke R; Bernhardt M; Grade M; Ghadimi BM; Gaedcke J World J Surg; 2015 Sep; 39(9):2329-35. PubMed ID: 25990502 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle. Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026 [TBL] [Abstract][Full Text] [Related]
20. MiR-20a promotes cervical cancer proliferation and metastasis in vitro and in vivo. Zhao S; Yao D; Chen J; Ding N; Ren F PLoS One; 2015; 10(3):e0120905. PubMed ID: 25803820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]